CLEAN : Uganda receives trial vaccines to help fight the spread of Ebola

The video discusses the arrival of 1200 vaccine doses from the Sabine Institute in the U.S. to Uganda. It highlights Uganda's proactive approach to handling outbreaks, emphasizing preparedness even in the absence of cases. The Ministry of Health continues research to combat potential Ebola outbreaks. The vaccine doses will be used for research and administered to those at greatest risk, particularly contacts of Sudan virus disease cases.

What is the significance of the 1200 doses mentioned in the video?

• They are vaccines for a different disease.

• They are being sent to another country.

• They are the first batch of vaccines received from the Sabin Institute.

• They are the total number of vaccines Uganda will receive.

Why does Uganda continue research even when there are no active cases?

• To avoid international criticism.

• To compete with other countries.

• To use up excess resources.

• To prepare for potential future outbreaks.

How many Ebola outbreaks has Uganda experienced so far?

• Ten

• Five

• Three

• Seven

What is the primary purpose of the vaccine candidates mentioned?

• To be discarded after testing.

• To be stored for future use.

• To be used for research purposes.

• To be sold to other countries.

Who are the vaccines intended for according to the video?

• The general public.

• Healthcare workers only.

• Immediate contacts of diagnosed individuals.

• International travelers.